» Articles » PMID: 20543590

Th17 Cell Dynamics in HIV Infection

Overview
Date 2010 Jun 15
PMID 20543590
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Th17 cells are a newly identified subtype of CD4 T cells that respond to bacterial and fungal antigens and are important in mucosal immunology. Because HIV infection results in loss of CD4 T cells as well as disruption to the gastrointestinal tract that causes microbial translocation and immune activation, Th17 cells potentially play an important role in HIV pathogenesis. Here we examine the relationship between Th17 cells and HIV disease pathogenesis.

Recent Findings: Th17 cells are preferentially lost from the gastrointestinal tract of HIV-infected individuals, which is not entirely due to direct infection, as Th17 cells can be infected in vivo, but are not preferentially infected. Long-term highly active antiretroviral therapy (HAART) can result in restoration of Th17 cells in the gastrointestinal, which may be associated with better disease prognosis. Furthermore, other cells, such as Vdelta1 T cells, can make IL-17 in vivo during HIV infection and may contribute to antibacterial immunity after loss of Th17 cells.

Summary: Recent studies have improved our understanding of the role for Th17 cells during HIV infection; however, more studies are needed to discern better the detrimental consequences of loss of Th17 cells during HIV infection.

Citing Articles

The role of pharmacomicrobiomics in HIV prevention, treatment, and women's health.

Swanson E, Basting C, Klatt N Microbiome. 2024; 12(1):254.

PMID: 39627860 PMC: 11613800. DOI: 10.1186/s40168-024-01953-3.


Melanoma in people living with HIV: Immune landscape dynamics and the role of immuno- and antiviral therapies.

Barger L, El Naggar O, Ha B, Romano G Cancer Metastasis Rev. 2024; 44(1):9.

PMID: 39609320 PMC: 11604825. DOI: 10.1007/s10555-024-10230-6.


From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy.

Brenchley J, Serrano-Villar S Microbiome. 2024; 12(1):113.

PMID: 38907315 PMC: 11193286. DOI: 10.1186/s40168-024-01825-w.


HIV-associated photodermatitis in African populations.

Isaacs T, Lehloenya R Front Allergy. 2023; 4:1159387.

PMID: 37216149 PMC: 10192905. DOI: 10.3389/falgy.2023.1159387.


The anti-caspase 1 inhibitor VX-765 reduces immune activation, CD4 T cell depletion, viral load, and total HIV-1 DNA in HIV-1 infected humanized mice.

Amand M, Adams P, Schober R, Iserentant G, Servais J, Moutschen M Elife. 2023; 12.

PMID: 36800238 PMC: 9937651. DOI: 10.7554/eLife.83207.


References
1.
Sumpter B, Dunham R, Gordon S, Engram J, Hennessy M, Kinter A . Correlates of preserved CD4(+) T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis. J Immunol. 2007; 178(3):1680-91. DOI: 10.4049/jimmunol.178.3.1680. View

2.
Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan A . IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008; 118(2):534-44. PMC: 2157567. DOI: 10.1172/JCI33194. View

3.
Chung D, Kasper D, Panzo R, Chitnis T, Grusby M, Sayegh M . CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol. 2003; 170(4):1958-63. DOI: 10.4049/jimmunol.170.4.1958. View

4.
Fenoglio D, Poggi A, Catellani S, Battaglia F, Ferrera A, Setti M . Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood. 2009; 113(26):6611-8. DOI: 10.1182/blood-2009-01-198028. View

5.
Macal M, Sankaran S, Chun T, Reay E, Flamm J, Prindiville T . Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol. 2008; 1(6):475-88. DOI: 10.1038/mi.2008.35. View